MRC1 and neoplasm: Structural modulation of CD206 using the synthetic ligand RP-182 suppresses tumor growth, prolongs survival, and reprograms M2 macrophages toward an M1 phenotype through endocytosis, phagolysosome formation, and autophagy (56).